Statement On The Baby RB Case - Muscular Dystrophy Campaign
Muscular Dystrophy Campaign's statement on this case:
The Baby RB case has highlighted issues which, although rarely brought to the attention of the media, can affect families coping with muscle disease. The Muscular Dystrophy Campaign recognises the tragic situation that Baby RB's parents find themselves in and that unfortunately the resolution of this case is devastating for all parties involved.
Congenital myasthenic syndrome is the collective term for a group of inherited congenital disorders that affect the way messages from the nerves are sent across to the muscles. Symptoms normally start in the first years of life with varied disability ranging from mild to severe muscle weakness.
The Muscular Dystrophy Campaign is here to provide support for all families affected by muscle disease through our freephone information support line and care team. We also continue to invest over £1million each year into pioneering research to find treatments and cures for muscle disease.
The Muscular Dystrophy Campaign
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Campaign, Muscular Dystrophy. "Statement On The Baby RB Case - Muscular Dystrophy Campaign." Medical News Today. MediLexicon, Intl., 15 Nov. 2009. Web.
9 Dec. 2016. <http://www.medicalnewstoday.com/releases/170915.php>
Campaign, M. (2009, November 15). "Statement On The Baby RB Case - Muscular Dystrophy Campaign." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.